with regard to the clinical steering committees, I would think that Prof. Kausik Ray is a given.  That tweet a couple of weeks ago would suggest that he is actively participating liaising with FDA on behalf of RVX, and I believe he has all the top drawer credentials to lead any CVOT.  I hope Dr. KKZ is back.  We haven't heard anything about cognitive impairment, so I wonder about Dr. Cummings.

I have 2 questions: (1) Who would they use as a NAFLD expert; and (2) wouldn't the eventual BP want their own input on who sits on the various committees?